Age (y) Sex Dose order Injection site LN side Symptoms Vaccination to lymphadenopathy interval* (d) Lymphadenopathy to referral interval (d) Referral to USS interval (d) Outcome+ Time for outcome (w)
1 54 F 1st Left Ipsilateral Tenderness 11 16 9 FR 8
2 27 F 1st Left Ipsilateral Tenderness 5 7 3 FR 3
3 60 F 1st Left Ipsilateral None 3 2 6 FR 2
4 40 M 1st Left Ipsilateral None 1 44 8 ND ND
5 76 F 1st Left Ipsilateral None 4 17 7 PR 5
6 41 F 1st Left Ipsilateral None 7 26 10 FR 2
7 73 F 1st Left Ipsilateral Tenderness 7 7 5 FR 3
8 55 F 1st Left Ipsilateral None 14 41 12 PR 12
9 57 F 1st Left Ipsilateral None 2 37 12 PR 11
10 56 F 2nd Left Ipsilateral Tenderness 1 45 12 PR 8
11 81 F 1st Right Ipsilateral Tenderness 10 38 10 PR 6
12 34 M 1st Left Ipsilateral None 2 3 4 FR 3
13 58 F 1st Left Ipsilateral None 2 2 7 FR 1